Our team at Millendo is relentlessly pursuing therapies that alleviate patient suffering due to endocrine diseases.
A message for Prader-Willi syndrome patients and families learn more.
Join Our Team
Discover how “Millendoers”
are making things happen and how you can join us
Millendo in the News
May 8, 2020
Millendo Therapeutics Reports First Quarter 2020 Operating and Financial Results
April 6, 2020
Millendo Therapeutics Announces Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome (PWS)
March 11, 2020
Millendo Therapeutics Reports Full Year 2019 Operating and Financial Results
